SL Science Holding Limited (SLBT)
NASDAQ: SLBTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 8, 11:38 AM ET
SLBT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $841.14M
- EPS (TTM)
- -$0.01
- Dividend yield
- None
- 52-week range
- 1.42 – 14.50
- Day range
- 1.50 – 1.55
- Volume / Avg
- 17.76K / 80.93K
- Beta
- —
- Shares outstanding
- 560.76M
52-week range
SLBT stock today
Shares of SL Science (SLBT) are trading lower on Oct 8 at $1.50, a drop of 0.66% or $0.01 per share, versus the S&P 500's 0.36% decline. Shares are 89.7% below their 52-week high of $14.50, set on Jun 16, 2026 and 5.6% above the 52-week low of $1.42, near the bottom of the past year's range. SLBT is down 85.7% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 85.4%.
SL Science has posted a net loss over the last twelve months (EPS of -$0.01), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About SL Science
Company profileSL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes.
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- CEO
- Mr. Ching-Dong Wang
- Headquarters
- Taipei
- Employees
- 14
- Website
- sl-bio.com
SL Science peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GLUEMonte Rosa Therapeutics Inc. | 9.82 | -3.44% | $837.78M | vs SLBT |
| ODTXOdyssey Therapeutics Inc. | 18.13 | +0.28% | $871.30M | vs SLBT |
| SANASana Biotechnology Inc. | 2.69 | -1.29% | $803.78M | vs SLBT |
| CGEMCullinan Therapeutics Inc. | 14.93 | -4.47% | $917.57M | vs SLBT |
| DNAGinkgo Bioworks Holdings Inc. Class A | 11.18 | -2.52% | $752.95M | vs SLBT |
| CADLCandel Therapeutics Inc. | 9.50 | -3.26% | $726.93M | vs SLBT |
| SLDBSolid Biosciences Inc. | 6.65 | -2.92% | $713.05M | vs SLBT |
| ATTOAttovia Therapeutics Inc. | 15.58 | -5.15% | $711.02M | vs SLBT |
Indexes, lists and sector
SL Science stock FAQ
What is SL Science's stock price today?
SLBT last traded at $1.50 as of Oct 8, 11:38 AM EDT, down 0.66% on the day. Prices are delayed at least 15 minutes.
Who is SL Science's CEO?
Mr. Ching-Dong Wang is the chief executive officer of SL Science Holding Limited, which has about 14 employees.
What is the SLBT 52-week high?
The 52-week high for SLBT is $14.50 and the 52-week low is $1.42. The stock is currently 89.7% below its high.